Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-09-09 | New | $2,405,000 | Unknown | Equity Only | SEC link | |
2024-09-16 | New | $2,730,773 | $2,730,773 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Steve Bourne | Executive |
Scott Boyer | Director, Executive |
Bruce Duncan | Director |
Kurt Florian | Director |
Carol Gavin | Director |
Troy Hammond | Director |
Matt Litfin | Director |
Paul Regan | Director |